{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-007738","form_type":"8-K","ticker":"IMNM","cik":"0001472012","company_name":"Immunome Inc.","filed_at":"2023-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.138439+00:00","generated_at":"2026-06-20T06:34:47.852270+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Immunome posts corporate presentation on website for investor meetings","bullets":["Posted presentation dated January 2023 under Item 8.01 of Form 8-K.","Presentation may be used in meetings with investors, analysts, collaborators, vendors.","Presentation attached as Exhibit 99.1 and incorporated by reference into Item 8.01.","Report signed by President and CEO Purnanand D. Sarma on January 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-007738","json":"https://secwatch.observer/filing/0001104659-23-007738.json","markdown":"https://secwatch.observer/filing/0001104659-23-007738.md","text":"https://secwatch.observer/filing/0001104659-23-007738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/0001104659-23-007738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/tm234730d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T06:34:47.852270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}